sustained-release - Top Search

Top Search

Trending News
DOBEY
ENTEX
FASTFOOD
film-radio-television
gallenbach
gallertig
glyphs
HELMINTH

Trending World Search
high-alumina
JAMAIL
JENNETT
jettisoned
KAVENEY
keystrokes
labiacee
marking-switch

Real Time - sustained-release

Ultra Hair Time Release - 90 - Sustained Release Tablet: "Nature's Plus has developed the absolute ultimate in a... http://t.co/6MAH5bug
25 May 2012, 8:42 pm
Ultra Hair Time Release - 90 - Sustained Release Tablet: "Nature's Plus has developed the absolute ultimate in a... http://t.co/6MAH5bug

Vitamin B-12 2000mcg Time Release - 60 - Sustained Release Tablet: "Each tablet supplies a precise daily measure... http://t.co/sN3VYp12
25 May 2012, 6:48 pm
Vitamin B-12 2000mcg Time Release - 60 - Sustained Release Tablet: "Each tablet supplies a precise daily measure... http://t.co/sN3VYp12

KAL - Pantothenic Acid, 1000 mg, 100 tablets: KAL offers 1000 mg of Pantothenic Acid in a sustained release vege... http://t.co/fcUmpc2T
25 May 2012, 6:35 pm
KAL - Pantothenic Acid, 1000 mg, 100 tablets: KAL offers 1000 mg of Pantothenic Acid in a sustained release vege... http://t.co/fcUmpc2T

#Oregano has only evr bn studied in humans 1 time. Sustained release, standardized, & emulsified TABLET produced gr8 results 4 parasites
25 May 2012, 6:29 pm
#Oregano has only evr bn studied in humans 1 time. Sustained release, standardized, & emulsified TABLET produced gr8 results 4 parasites

Matrix 2.0 Sustained Release Protein (2 lb. bottle): Matrix 2.0 Sustained Release Protein Blend mixes instantly ... http://t.co/Ry0q7xiY
25 May 2012, 6:06 pm
Matrix 2.0 Sustained Release Protein (2 lb. bottle): Matrix 2.0 Sustained Release Protein Blend mixes instantly ... http://t.co/Ry0q7xiY

NOW Foods Vitamin C-1000 Sustained Release with Rose Hips, 250 Tablets: Our 1000 mg C with added rose hips conti... http://t.co/FiqinEuj
25 May 2012, 4:47 pm
NOW Foods Vitamin C-1000 Sustained Release with Rose Hips, 250 Tablets: Our 1000 mg C with added rose hips conti... http://t.co/FiqinEuj

Vitamin Shoppe - B-Complex 125, 100 tablets: Our highest potency B-Complex in a sustained release formula that p... http://t.co/IwEQxz5A
25 May 2012, 3:57 pm
Vitamin Shoppe - B-Complex 125, 100 tablets: Our highest potency B-Complex in a sustained release formula that p... http://t.co/IwEQxz5A

Active Lipoic Acid "Sustained Release" 60 Tablets: Active Lipoic Acid "Sustained Release"- A powerful Antioxidan... http://t.co/Wzdvhnow
25 May 2012, 2:42 pm
Active Lipoic Acid "Sustained Release" 60 Tablets: Active Lipoic Acid "Sustained Release"- A powerful Antioxidan... http://t.co/Wzdvhnow

AOR R + SR Lipoc Acid Sustained Release - 60 Vcaps: R(+)SR is formulated in a special matrix to provide a sustai... http://t.co/0kEwba5z
25 May 2012, 2:11 pm
AOR R + SR Lipoc Acid Sustained Release - 60 Vcaps: R(+)SR is formulated in a special matrix to provide a sustai... http://t.co/0kEwba5z

Vitalabs Mega-2, Sustained Release, 180 Tablets: Multi Vitamin/Mineral Supplement. The natural choice. Contains ... http://t.co/kcud8ogB
25 May 2012, 1:38 pm
Vitalabs Mega-2, Sustained Release, 180 Tablets: Multi Vitamin/Mineral Supplement. The natural choice. Contains ... http://t.co/kcud8ogB

Trends: Time Release andquotNatures absolute ultimate tablet tcosNVYp tcofcUmpcT

News - sustained-release

pSivida Corp. Announces Expiration of 2.7 Million Warrants
17 May 2012, 7:00 am
pSivida Corp. , a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced the expiration on May 15, 2012 of warrants to purchase 2,735,337 shares of pSivida common stock.

Elixir Medical Announces Continued Excellent One Year Safety and Efficacy Data from the EXCELLA BD Randomized Clinical ...
15 May 2012, 9:18 am
Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced one-year randomized clinical trial result

pSivida Corp. Reports Results for the Third Quarter Ended March 31, 2012
9 May 2012, 7:00 am
pSivida Corp. , a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced financial resul

Press Release
7 May 2012, 8:08 am
pSivida Corp. Posted on:07 May 12 pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced the Medicines and Healthcare products Regulatory Agency of the United Kingdom (MHRA) has granted marketing authorization for ILUVIEN® for the treatment of vision impairment associated with chronic ...

pSivida Corp. Announces United Kingdom Grants ILUVIEN® Marketing Authorization for the Treatment of Chronic Diabetic ...
7 May 2012, 7:33 am
pSivida Corp. , a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced the Medicines and Healthcare products Regulatory Agency of the United Kingdom has granted marketing authorization for ILUVIEN® for the treatment of vision impairment associated with chronic diabetic macular edema considered insufficiently responsive to ...

United Kingdom Grants ILUVIEN(R) Marketing Authorization for the Treatment of Chronic Diabetic Macular Edema
7 May 2012, 7:30 am
ATLANTA -- Alimera Sciences, Inc., (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced ...

Ocular Therapeutix initiates travoprost-loaded punctum plug trial in glaucoma
5 May 2012, 3:14 am
Ocular Therapeutix, Inc. announced today the commencement of a sustained release travoprost-loaded punctum plug feasibility study for the treatment of glaucoma.

Ocular Therapeutix Commences a Sustained Release Travoprost Punctum Plug Feasibility Study for Treatment of Glaucoma
4 May 2012, 10:19 pm
BEDFORD, Mass., May 4, 2012 /PRNewswire/ -- Ocular Therapeutix, Inc. announced today the commencement of a sustained release travoprost-loaded punctum plug feasibility study for the treatment of glaucoma. Up ...

pSivida Corp Announces Third Quarter 2012 Financial Results Release Date and Conference Call Information
3 May 2012, 8:00 am
pSivida Corp. , a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that its financial results for the third quarter of fiscal year 2012 will be released before the market open on Wednesday, May 9, 2012, followed the same day by a conference call and live webcast scheduled for 8:30 a.m.

Ophthalmic Drugs: World Market Prospects 2012-2022
2 May 2012, 4:03 am
NEW YORK, May 2, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Ophthalmic Drugs: World Market Prospects 2012-2022 http://www.reportlinker.com/p0847305/Ophthalmic-Drugs-World-Market-Prospects-2012-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_MedicationReport ...

Trends: Announces Million Data EXCELLA Randomized Clinical Ended Diabetic

World - sustained-release

Vaporizers prove effective in treating medical marijuana patients - Washington Times
25 May 2012, 3:00 pm
The study showed that patients could reduce the amount of opiates (sustained release morphine or oxycodone) when combined with vaporized cannabis to get this effect. Vaporizers can provide other health benefits as well. Aromatherapy can help ...

Transgene Biotek gets satisfactory results from its TrabiOral technologies - pharmabiz.com
24 May 2012, 6:40 am
TrabiOral has shown controlled and sustained release of the active molecules, which would result in much better control of administration through maintenance of steadier plasma levels, and often decrease side effects by reducing peak plasma levels.

Expert Advice: Dr. Jaliman’s Summer Skin Care Tips - GlamScene (blog)
22 May 2012, 10:53 am
The broad-spectrum sunscreen can protect you from both UVA/UVB rays, and a retinol with a sustained release also containing hyaluronic acid to keep skin quenched. Brown spots will start fading and skin will start smoothing out after a week of use.

Elite Pharmaceuticals Announces Issuance of U.S. Patent for Abuse Resistant Oral Dosage Formulation - msnbc.com
22 May 2012, 8:44 am
Elite's lead pipeline products include a once-daily abuse resistant opioid, and a once-daily opioid. They are sustained release oral formulations of opioids for the treatment of chronic pain, which address two of the limitations of existing ...

Amount counts for 'healthy' burgers - heraldsun.com.au
19 May 2012, 8:05 am
"Choose a wholegrain bun for a sustained release of energy, choose lean meats such as beef, chicken or fish and top the burger with plenty of fresh salad."

Shares of Alkermes Under Pressure, Down 3.8% - Financial News Network Online
17 May 2012, 11:45 pm
Alkermes, Inc. develops products based on drug delivery technologies. The Company is focusing on controlled, sustained release of injectable drugs, as well as the delivery of drugs into the brain past the blood-brain barrier. Alkermes is also focusing on ...

Alkermes Reports Narrower-Than-Expected Loss (ALKS) - Financial News Network Online
17 May 2012, 7:45 am
Alkermes, Inc. develops products based on drug delivery technologies. The Company is focusing on controlled, sustained release of injectable drugs, as well as the delivery of drugs into the brain past the blood-brain barrier. Alkermes is also focusing on ...

pSivida Corp. Announces Expiration of 2.7 Million Warrants - Yahoo Finance
17 May 2012, 6:55 am
pSivida Corp. (NASDAQ: PSDV - News) (ASX: PVA.AX - News), a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced the expiration on May 15, 2012 of warrants to purchase ...

China Pharma Holdings, Inc. Earnings Conference Call (Q1 2012) - Yahoo! Finance
14 May 2012, 10:37 pm
Naproxen Sodium and Pseudophedrine Hydrochloride Sustained Release tablets to relieve cold, sinus and flu symptoms; Cefalexin Capsules for acute tonsillitis; and Anhydroandrographolide, used for clearing heat and detoxify. In addition, it provides ...

Punctal plug tested as glaucoma treatment - ModernMedicine
14 May 2012, 1:04 pm
Bedford, MA—Ocular Therapeutix has begun a feasibility study of a punctal plug delivering sustained-release travoprost (Travatan and Travatan Z, Alcon; Travo-Z, MicroLabs) to treat glaucoma. As many as 20 patients with documented ocular ...

Trends: medical marijuana Washington Times technologies Dosage Formulation msnbccom